Hämeenkyrö MSWI risk assessment: Dioxin: Difference between revisions
Jump to navigation
Jump to search
Line 143: | Line 143: | ||
|References = | |References = | ||
}} | }} | ||
Line 181: | Line 182: | ||
* In this specific case it is relevant to think about health effects of long-term exposure on human population. Also the risk | * In this specific case it is relevant to think about health effects of long-term exposure on human population. Also the risk | ||
of accidental exposure is low; only if the burning process is working improperly the amount of | of accidental exposure is low; only if the burning process is working improperly the amount of dioxin emissions will | ||
increase. | increase. | ||
Line 192: | Line 193: | ||
daily intake (TDI) is set in a range of 1-4 pg TEQs/kg bodyweight/day. | daily intake (TDI) is set in a range of 1-4 pg TEQs/kg bodyweight/day. | ||
* health effetcs of low doses should be modelled from animal data and | * health effetcs of low doses should be modelled from animal data and existing human data. Eg. on tooth development exists a | ||
Alaluusua et al. 1996). | study by Alaluusua et al. (1996). In a study by Miettinen et al. (2005) exposure to 0.5 μg TCDD/kg body weight on GD 15 | ||
resulted in maternal adipose tissue concentration 2185 pg/g fat. In that study linear extrapolation of the data predicts a | resulted in maternal adipose tissue concentration 2185 pg/g fat. In that study linear extrapolation of the data predicts a | ||
Line 203: | Line 204: | ||
to the highest values measured in the Finnish average population (PCDD/F 145.5 pg WHO-TEQ/g fat, Kiviranta et al. 2005). | to the highest values measured in the Finnish average population (PCDD/F 145.5 pg WHO-TEQ/g fat, Kiviranta et al. 2005). | ||
|Inputs = *Dioxin emissions and in Hämeenkyrö ''(Comment: This is not actually an input, but [[#Dioxin exposure due to | |Inputs = *Dioxin emissions and in Hämeenkyrö ''(Comment: This is not actually an input, but [[#Dioxin exposure due to | ||
Line 229: | Line 228: | ||
van Leeuwen FX et.al. Chemosphere. 2000 May-Jun;40(9-11):1095-101. | van Leeuwen FX et.al. Chemosphere. 2000 May-Jun;40(9-11):1095-101. | ||
Alaluusua et al. Eur J Oral Sci. 1996 Oct-Dec;104(5-6):493-7. | Alaluusua et al. Eur J Oral Sci. 1996 Oct-Dec;104(5-6):493-7. | ||
Miettinen HM et al. Toxicol Sci. 2005 Jun;85(2):1003-12. | Miettinen HM et al. Toxicol Sci. 2005 Jun;85(2):1003-12. | ||
Kiviranta et al. Chemosphere. 2005 Aug;60(7):854-69. | Kiviranta et al. Chemosphere. 2005 Aug;60(7):854-69. | ||
}} | }} |
Revision as of 08:00, 22 September 2006
See the main page of this assessment: Hämeenkyrö MSWI risk assessment: General
Dioxin emissions in Hämeenkyrö
Virpi
Intake fraction for dioxin emissions from Hämeenkyrö
Intake fraction for dioxin emissions from Hämeenkyrö
Baseline dioxin exposure in Hämeenkyrö
Marjo
Baseline dioxin exposure in Hämeenkyrö
Dioxin exposure due to MSWI in Hämeenkyrö
Martin
Health effects caused by dioxin exposure
Sanna
Responses of dioxin exposure on human health at the population level